Drugs / Investigational Tdap vaccine Formulation D
Investigational Tdap vaccine Formulation D
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03958799 | Jun 2019 → Apr 2021 | — | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Investigational Tdap vaccine Formulation D | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03958799 ↗ |
| Modality | Vaccine | “Investigational Tdap vaccine Formulation D” NCT03958799 ↗ |